Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allovir, Alphamab, CSPC, Nrx, Oncolyze, Oncotelic, Oncternal, Samsung, Simcere.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Endotronix, Nuvasive.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Abbvie, Abionyx, Adverum, Akeso, Amylyx, Ananda, Astrazeneca, Cstone, Cullinan, Everest, Iliad, Genprex, Immix, Jazz, Knight, Melt, Nordic, Novavax, Oryzon, Pfizer, PTC, Spero, Splisense, Verseau, Viridian.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Amniotics, Astrazeneca, Cstone, Daiichi Sankyo, Mesoblast, Novavax, Nrx, RDIF, Regor.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Injeq.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Lexicon, Mesoblast, Xeris.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Immunovant.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Siemens Healthineers.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Beyondspring, Bionomics, Bioxcel, CTI, Cytodyn, Harmony, Huyabio, Innovent, Merck, Moleculin, Ridgeback, Shenzhen Chipscreen, Secura, Siga, Statera, Surface, Telix, VBI, Zogenix.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Paragon 28.